Long-standing Expertise Senn Chemicals has been operating in the peptide and pharmaceutical manufacturing sector since 1963, demonstrating a deep expertise and a proven track record in developing high-quality peptide APIs, which can be leveraged for expanding client collaborations and custom product development.

Innovation Focus Recent development of GLP-1 based APIs indicates ongoing innovation and capacity for cutting-edge peptide therapeutics, presenting opportunities to partner with biotech and pharma companies seeking advanced APIs and tailored solutions.

Recent Acquisition The recent acquisition by Granules India for approximately $22.2 million suggests a strong industry validation and potential for increased sales through the integration of Senn's capabilities into a larger global distribution network.

Diverse Product Portfolio Senn offers a range of products including peptides, amino acid derivatives, nucleotides, and excipients, opening multiple avenues for sales in various segments of the pharmaceutical and biotech supply chain.

Global Market Reach With manufacturing services from discovery to cGMP production and a worldwide client base in biotech, pharma, diagnostics, cosmeceuticals, and veterinary sectors, there are numerous opportunities to expand sales by targeting innovative drug developers and generic product manufacturers.